Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced NSCLC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Early research (Phase 1)Ended earlyNCT01124812
What this trial is testing

131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Philogen S.p.A. 3
Early research (Phase 1)Active Not RecruitingNCT06883630
What this trial is testing

A Phase Ib Study of RC148 as Monotherapy or Combination for Locally Advanced or Metastatic NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
RemeGen Co., Ltd. 121
Testing effectiveness (Phase 2)Looking for participantsNCT07037680
What this trial is testing

Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT

Who this might be right for
Locally Advanced Non-Small Cell Lung CancerThoracic RadiotherapySafety
JIANYANG WANG 44
Testing effectiveness (Phase 2)Study completedNCT02841579
What this trial is testing

Osimertinib (AZD9291) in First-line Locally Advanced or Metastatic NSCLC Patients With EGFR and EGFR T790M

Who this might be right for
Non-Small Cell Lung Cancer
MedSIR 22
Testing effectiveness (Phase 2)Study completedNCT00495170
What this trial is testing

Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 84
Testing effectiveness (Phase 2)Study completedNCT01107444
What this trial is testing

Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Eli Lilly and Company 180
Testing effectiveness (Phase 2)UnknownNCT04749394
What this trial is testing

Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy

Who this might be right for
Locally Advanced Non-Small Cell Lung Cancer
Chinese Academy of Medical Sciences 42
Not applicableStudy completedNCT01664533
What this trial is testing

An Observational Study of Erlotinib (Tarceva) as Second-line Treatment in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Failure of Pemetrexed in First-line Therapy

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 57
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07670715
What this trial is testing

Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant Response

Who this might be right for
Locally Advanced Non-small Cell Lung Cancer (NSCLC)Thoracic RadiotherapyImmune Checkpoint Inhibitors+1 more
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07264816
What this trial is testing

BL-M07D1 in Combination With Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic HER2-Overexpressing Non-Squamous NSCLC

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 80
Testing effectiveness (Phase 2)Looking for participantsNCT05267626
What this trial is testing

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc. 159
Testing effectiveness (Phase 2)Study completedNCT00434135
What this trial is testing

Alimta and Gemcitabine in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerStage IIIB or IV
Southern Italy Cooperative Oncology Group 180
Large-scale testing (Phase 3)UnknownNCT04325763
What this trial is testing

TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC)

Who this might be right for
Stage III Non-small-cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 315
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07750704
What this trial is testing

Lorlatinib Plus Sacituzumab Tirumotecan With Peripheral ctDNA Guidance as First-Line Therapy for ALK Fusion-Positive NSCLC

Who this might be right for
ALK Positive Non-small Cell Lung Cancer
Guangdong Association of Clinical Trials 153
Very early researchUnknownNCT02568033
What this trial is testing

Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
The Cooper Health System 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04152499
What this trial is testing

Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)

Who this might be right for
Epithelial Ovarian CancerGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+7 more
Klus Pharma Inc. 1,410
Testing effectiveness (Phase 2)Study completedNCT02552121
What this trial is testing

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

Who this might be right for
Ovary CancerCervix CancerEndometrium Cancer+4 more
Seagen Inc. 33
Large-scale testing (Phase 3)Study completedNCT00418886
What this trial is testing

Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients

Who this might be right for
Non Small Cell Lung CancerLung Cancer
Genzyme, a Sanofi Company 698
Testing effectiveness (Phase 2)Looking for participantsNCT06749860
What this trial is testing

Disitamab Vedotin in Combination with Tislelizumab and Bevacizumab in a Phase II Clinical Study of Locally Advanced or Metastatic Non-small Cell Lung Cancer with HER2 Mutation/amplification/expression

Who this might be right for
Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 58
Next Page